1081809-48-4 Usage
Description
(2E)-N-(3,4-dichlorophenyl)-2-hydroxyimino-acetamide is a chemical compound with the molecular formula C8H7Cl2NO2. It is a hydroxyimino-acetamide derivative with a trans configuration, characterized by an E configuration where the functional groups are on opposite sides of the double bond. (2E)-N-(3,4-dichlorophenyl)-2-hydroxyimino-acetamide contains a hydroxyimino group and a dichlorophenyl group, which may contribute to its potential applications in pharmaceuticals or other chemical industries. Further research is required to fully understand its properties and explore its potential uses in drug development.
Uses
Used in Pharmaceutical Industry:
(2E)-N-(3,4-dichlorophenyl)-2-hydroxyimino-acetamide is used as a potential pharmaceutical compound for its possible biological activities. The presence of a hydroxyimino group and a dichlorophenyl group may provide it with unique properties that could be harnessed in drug development, although more research is needed to confirm its efficacy and safety.
Used in Chemical Research:
In the field of chemical research, (2E)-N-(3,4-dichlorophenyl)-2-hydroxyimino-acetamide serves as a subject for studying the effects of different functional groups on the compound's properties. Its E configuration and the specific arrangement of atoms may offer insights into the behavior of similar compounds and contribute to the advancement of chemical knowledge.
Check Digit Verification of cas no
The CAS Registry Mumber 1081809-48-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,8,1,8,0 and 9 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1081809-48:
(9*1)+(8*0)+(7*8)+(6*1)+(5*8)+(4*0)+(3*9)+(2*4)+(1*8)=154
154 % 10 = 4
So 1081809-48-4 is a valid CAS Registry Number.
1081809-48-4Relevant articles and documents
INDIRUBIN-TYPE COMPOUNDS, COMPOSITIONS, AND METHODS FOR THEIR USE
-
Page/Page column 23-24; Figure 2A, (2008/06/13)
Compounds and compositions including 6-bromo-indirubin, 5-amino-indirubin and N-methyl-indirubins and related indirubin derivatives are provided that are useful as selective modulators of glycogen synthase kinase-3, cyclin-dependent protein kinases or aryl hydrocarbon receptors. Methods of inhibiting or modulating cell growth or cell cycling are provided using the compounds of the invention. In other aspects, compounds and methods for the treatment of protozoan-mediated diseases, Alzheimer's disease and diabetes are provided.
